Seng and Tamiflu drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Seng (ginseng, panax) and Tamiflu (oseltamivir phosphate). Common drug interactions include abdominal distension among males.
The phase IV clinical study analyzes what interactions people have when they take Seng and Tamiflu. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Seng?
Seng has active ingredients of ginseng, panax. eHealthMe is studying from 1,152 Seng users. Check the latest studies of Seng.
What is Tamiflu?
Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.
30 people who take Seng and Tamiflu together, and have interactions are studied.
What are the common drug interactions of Seng and Tamiflu, by gender? *:
female:
n/a
male:
- Abdominal distension
- Vomiting
- Stress
- Abdominal pain
- Appendicitis (inflammation of the appendix)
- Ascites (accumulation of fluid in the abdominal cavity)
- Constipation
- Nausea (feeling of having an urge to vomit)
- Dry mouth
- Dyspnoea (difficult or laboured respiration)
What are the common drug interactions of Seng and Tamiflu, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Abdominal distension
- Vomiting
- Stress
- Abdominal pain
- Appendicitis (inflammation of the appendix)
- Ascites (accumulation of fluid in the abdominal cavity)
- Constipation
- Nausea (feeling of having an urge to vomit)
- Dry mouth
- Cardiogenic shock (inadequate circulation of blood)
What are the existing conditions these people have? *
- Ventricular Fibrillation (abnormally irregular heart rhythm): 30 people, 100.00%
- Iron Deficiency: 30 people, 100.00%
- Bacterial Infection: 30 people, 100.00%
- Blood Phosphorus Increased: 30 people, 100.00%
- Blood Uric Acid Increased: 30 people, 100.00%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 30 people, 100.00%
- Constipation: 30 people, 100.00%
- Diabetes: 30 people, 100.00%
- Dyspnea (difficult or laboured breathing): 30 people, 100.00%
- Thrombosis (formation of a blood clot inside a blood vessel): 30 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Seng and Tamiflu?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Seng and Tamiflu:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Seng:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tamiflu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Seng and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tamiflu and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ginseng, panax and oseltamivir phosphate (the active ingredients of Seng and Tamiflu, respectively), and Seng and Tamiflu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Humira cause Neuromyopathy? - 4 seconds ago
- Drug interactions of Letrozole and Gentamicin - 4 seconds ago
- Could Paxil cause Left Ventricular Hypertrophy? - 5 seconds ago
- How effective is Amitril for Fibromyalgia? - 5 seconds ago
- Could Peg-Intron cause Stress And Anxiety? - 11 seconds ago
- Allegra-D 24 Hour Allergy And Congestion vs. Beldin, side effect and effectiveness comparison - 19 seconds ago
- Could Arnuity Ellipta cause Sputum Discolored? - 21 seconds ago
- Could Gadavist cause Contrast Media Reaction? - 32 seconds ago
- Drug interactions of Oxycodone and Tigan - 39 seconds ago
- Could Albuterol cause Bell'S Palsy? - 52 seconds ago